Table of Contents Table of Contents
Previous Page  321 / 879 Next Page
Information
Show Menu
Previous Page 321 / 879 Next Page
Page Background

Are MDMs cost effective? Advantages of MDMs

There were two non-randomised studies that reported results of

MDMs in cancer care

:

Fader et al (1998): with

melanoma

,

the costs of health

care were 33% to 50% lower

in patients whose

management decisions were made by an MDM

Hagiwara et al. (2011): team for patients with

haematologic

malignancies

.

It was found that incidences of hepatic

complications, hyperglycemia, and central venous catheter

infection were lower in the ‘after’ group than in the ‘before’

group, and

costs fell by about 20%